A novel anti-inflammatory role for thymosin beta 4 sulfoxide in a murine model of allergic asthma

A. McKay, B. P. Leung, I. B. McInnes, J. D. Young, R. D. Stevenson, N. C. Thomson, F. Y. Liew (Glasgow, United Kingdom)

Source: Annual Congress 2002 - Asthma: animal models
Session: Asthma: animal models
Session type: Oral Presentation
Number: 3523
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. McKay, B. P. Leung, I. B. McInnes, J. D. Young, R. D. Stevenson, N. C. Thomson, F. Y. Liew (Glasgow, United Kingdom). A novel anti-inflammatory role for thymosin beta 4 sulfoxide in a murine model of allergic asthma. Eur Respir J 2002; 20: Suppl. 38, 3523

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Neu-164, a novel antioxidant and anti-inflammatory compound reduces lung inflammation in a murine model of allergic asthma
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008

Effect of SMP-028, a novel anti-inflammatory agent, on experimental allergic asthma in guinea pig model
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010

Critical immunoregulatory role for activin-A in human allergic asthma
Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Year: 2011

Role of mouse mast cell protease 4 in a murine model of allergic asthma
Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma
Year: 2007


Anti-inflammatory and anti-asthmatic effects of resolvin E1 in a mouse model of allergic asthma
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009


Neutraligands of CXCL12: Anti-inflammatory activity in an allergic model of asthma
Source: Annual Congress 2011 - Models of disease and drug actions
Year: 2011


IL-13-dependent C3a-release in a murine model of allergic asthma
Source: Annual Congress 2005 - Airway epithelial cells in asthma and COPD
Year: 2005


An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in the mouse
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013

Overexpression of eNOS suppresses asthmatic features in a mouse model of allergic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 28s
Year: 2002

Pharmacological characterization of the protective effect of mepolizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019

Effect of a pan-JAK inhibitor pyridone 6 on airway responses in murine asthma model
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010

Relationships between glutaredoxin 1 and cytokine levels in a murine model of allergic airway inflammation
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013

Protective effect of thrombomodulin in a murine model of allergen-induced asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010

Pharmacological characterization of the protective effect of benralizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019

Murine models of asthma
Source: Eur Respir J 2003; 22: 374-382
Year: 2003



Der p 2-derived peptide abrogates HDM-induced allergic asthma in mouse and humanized model
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019

Effect of oral procaterol on allergic inflammation examined by a murine asthmatic model
Source: Eur Respir J 2003; 22: Suppl. 45, 286s
Year: 2003

The effect of anti-inflammatory treatment on bacterial rhino-sinusitis in a murine model
Source: Eur Respir J 2002; 20: Suppl. 38, 618s
Year: 2002

The therapeutic efficacy of OAT-889 (dual AMCase/CHIT1 inhibitor) in comparison to montelukast in HDM-induced model of chronic airway inflammation in mice
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017

Investigations on the role of region-specific IL-13 receptor alpha 1 expression along the airway tree in mucus production in asthma
Source: Annual Congress 2012 - Mechanistic studies in airway cell biology
Year: 2012